Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Towards vaccine optimisation.

A R Lussow1, M T Aguado, G Del Giudice

  • 1World Health Organisation-Immunology Research and Training Centre, Dept. of Pathology, University of Geneva, Switzerland.

Immunology Letters
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An ancestral molecular response to nanomaterial particulates.

Nature nanotechnology·2023
Same author

Two apparently unrelated groups of symbiotic annelids, Nautiliniellidae and Calamyzidae (Phyllodocida, Annelida), are a clade of derived chrysopetalid polychaetes.

Cladistics : the international journal of the Willi Hennig Society·2021
Same author

Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity.

Nature communications·2020
Same author

Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Multivariate probability distribution for sewer system vulnerability assessment under data-limited conditions.

Water science and technology : a journal of the International Association on Water Pollution Research·2016
Same author

Making the immune system work.

Immunology today·2014
Same journal

The dendritic cell identity crisis: why conflicting classifications demand a consensus framework?

Immunology letters·2026
Same journal

The malignancy within: what cancer teaches us about human bonds.

Immunology letters·2026
Same journal

Progranulin enhances complement component 5a-primed neutrophil activation in antineutrophil cytoplasmic antibody-associated vasculitis.

Immunology letters·2026
Same journal

The newly identified role of TRIM72, an E3 ligase, in NINJ1-mediated plasma membrane rupture: focus on its anti-inflammatory function.

Immunology letters·2026
Same journal

The subsets of circulating follicular helper T cells play an important role in the pathogenesis of Autoimmune thyroid diseases.

Immunology letters·2026
Same journal

Could bradykinin pathway inhibition change the course of severe hantavirus disease?

Immunology letters·2026
See all related articles

Optimizing subunit candidate vaccines involves tailoring antigen use to target populations and enhancing immune responses. Novel delivery systems and strategies are crucial for effective vaccine development and deployment.

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Subunit candidate vaccines are rapidly identified using new molecular technologies.
  • Optimizing antigen use is critical for maximizing vaccine benefits and ensuring field applicability.
  • Vaccine development must consider target population needs and economic constraints.

Purpose of the Study:

  • To discuss strategies for optimizing subunit candidate vaccines.
  • To highlight the importance of tailoring vaccine approaches to specific epidemiological problems.
  • To explore methods for enhancing protective immune responses.

Main Methods:

  • Review of current approaches in vaccine optimization.
  • Discussion of novel vaccine delivery systems.

Related Experiment Videos

  • Exploration of strategies for potentiating immune responses.

    • Main Results:

    • Antigen optimization should align with population needs and economic feasibility.
    • Novel delivery systems can improve vaccine stability, reduce dosage, and facilitate administration.
    • Selective induction of specific immune effectors (antibody isotypes, T-cell subsets) is increasingly achievable.

    Conclusions:

    • Vaccine optimization requires a multifaceted approach, integrating antigen selection, delivery systems, and immune response modulation.
    • Safety considerations beyond regulatory standards are vital for field deployment.
    • Continued innovation in vaccine strategies is essential for addressing global health challenges.